Orf
Orf (also called ecthyma contagiosum or contagious pustular dermatitis) is a re-emerging infection passed from animals to people (a zoonosis). It is caused by orf virus, a double-stranded DNA virus in the genus Parapoxvirus, family Poxviridae. The virus circulates mainly in small ruminants such as sheep and goats. It enters human skin through tiny scratches during direct contact with infected animals, raw meat or contaminated farm equipment. For this reason, orf is a characteristic occupational skin disease of farmers, veterinarians, slaughterhouse workers and food handlers.
Unlike the orthopoxviruses that cause severe, whole-body illness (such as smallpox and mpox), orf virus produces a strictly localized skin lesion. It is marked by rapid thickening of the epidermis (acanthosis) and inflammation with necrosis of the blood vessels in the upper dermis. Under the electron microscope, parapoxviruses are oval, with crisscrossing protein strands on their surface that resemble a ball of yarn. In people with a normal immune system the infection is self-limiting, passing through 6 distinctive morphologic stages over 4–6 weeks.
At Haute-Derma, although orf is benign, we place great importance on an accurate diagnosis to rule out dangerous, urgent skin infections such as cutaneous anthrax, herpetic whitlow and lesions caused by Francisella tularensis. Our approach focuses on conservative care of the lesion, preventing secondary bacterial infection, using precision laser treatment for giant orf in immunocompromised patients, and achieving the best cosmetic result without unsightly scarring.
How Orf Develops
Route of Entry and Epidermal Overgrowth
- How the virus gets in: Orf virus cannot cross intact skin. It needs a tiny break in the skin, such as a scratch, a thorn prick or a hangnail.
- Cell overgrowth and degeneration: The virus produces a VEGF-like growth factor along with proteins that suppress the host's immune defenses. This drives explosive growth of the spinous cell layer (acanthosis), thickening of the stratum corneum and ballooning degeneration of epidermal cells, with dilated blood vessels and bleeding in the dermal papillae.
Immune Response and Self-Resolution: Cell-mediated immunity (the T-cell response) is the key to controlling the virus. From the second week onward, CD4+ and CD8+ T cells and macrophages flood into the lesion and neutralize the virus particles, so the lesion regresses and crusts over naturally without systemic antiviral drugs.
The 6 Clinical Stages of Orf
A classic orf lesion is usually single (sometimes 2 or 3) and appears on the hand, a finger or the forearm. It moves through 6 characteristic stages, each lasting about a week:
- Maculopapular stage: A single, well-defined red bump 2–5 mm across appears where the virus entered, with mild itching or a superficial burning feeling.
- Targetoid stage: The lesion enlarges into a nodule or plaque 1–3 cm across with a distinctive three-ring target pattern – a dark red or dull necrotic center, a ring of opaque white (swollen epidermal cells) and an outer rim of red, congested skin.
- Acute (weeping) stage: The surface becomes moist and oozes clear or slightly bloody fluid, forming what looks like a pustule (pseudopustule). It feels firm to the touch, however, and contains no free pus.
- Regenerative stage: The surface gradually dries, and tiny black dots appear on a pink, granular base – these are dilated dermal papillary vessels that have clotted.
- Papillomatous stage: The lesion stands up from the skin, with a bumpy, wart-like or dry, fleshy surface and sharp borders.
- Regressive stage: The lesion shrinks and dries into a firm crust that gradually falls off, leaving fresh pink skin that recovers fully without a deep, pitted scar.
How Orf Is Diagnosed at Haute-Derma
Exposure History and Dermoscopy:
- We take a detailed history of contact with livestock (sheep, goats, cattle) or handling of raw meat during the previous 1–2 weeks.
- Dermoscopy: At the targetoid stage, the lesion shows a dull red center without pus, surrounded by an opaque white collar, with a network of linear and dotted vessels around the base of the nodule.
Direct Microscopy and Cultures to Rule Out Secondary Infection: A surface swab is Gram-stained and cultured to exclude secondary infection with Staphylococcus aureus or Streptococcus pyogenes.
Confirming the Diagnosis (Complex Cases):
- Parapoxvirus real-time PCR: Detects orf virus-specific DNA in a biopsy sample or crust.
- Electron microscopy (EM): Reveals the oval parapoxvirus particles with their characteristic crisscross, yarn-like protein strands.
How Orf Is Managed and Treated at Haute-Derma
Conservative Care and Prevention of Secondary Infection
- Local antisepsis: Clean the lesion twice daily with octenidine dihydrochloride or nano-silver solution. Cover it loosely with sterile gauze to prevent friction and stop the virus from spreading to other areas of skin.
- Topical antibiotics (if secondary infection is a risk): Apply mupirocin 2% or fusidic acid 2% ointment twice daily around the edge of the lesion if there is yellow discharge or spreading redness and soreness.
- Symptom relief: Acetaminophen (paracetamol) or ibuprofen for a mild fever or swollen, tender reactive lymph nodes.
Managing Complicated and Giant Orf
In people with weakened immunity (HIV, or anti-rejection drugs after an organ transplant), orf can grow into an unusually large, exophytic tumor-like mass that does not resolve on its own:
- Immune-stimulating / antiproliferative topicals: Imiquimod 5% cream 3 times a week or topical cidofovir 1% to boost the cell-mediated immune response against the virus.
- Cryotherapy: Liquid nitrogen is used to freeze large papillomatous growths.
- Precision CO₂ laser / Nd:YAG 1064 nm: CO₂ laser energy vaporizes giant orf growths without bleeding, reducing the size of the lesion and speeding healing.
